石墨烯
生物传感器
痴呆
材料科学
疾病
纳米技术
晶体管
医学
生物标志物
检出限
化学
内科学
色谱法
生物化学
物理
电压
量子力学
作者
Dongsung Park,Jae‐Hyun Kim,Hye Jin Kim,Dongtak Lee,David S. Lee,Dae Sung Yoon,Kyo Seon Hwang
标识
DOI:10.1016/j.bios.2020.112505
摘要
Alzheimer's disease (AD) is a neurodegenerative disease that accounts for 70% of all dementia. Early stage diagnosis of AD is essential as there is no certain treatment after the lesion has progressed in the late stage. Nevertheless, there are still limitations of early diagnosis of AD using neuroimaging and psychological memory assessments. Here, we demonstrate ultrasensitive and multiplexed detection of pivotal AD biomarkers (Aβ1-42 and t-Tau) in biofluids using a reduced graphene oxide field-effect transistor (gFET). The proposed approach provides a wide logarithmically linear range of detection from 10−1–105 pg mL−1 and a femtomolar-level limit of detection in biofluids (human plasma and artificial cerebrospinal fluid) as well as phosphate-buffered saline (PBS). Furthermore, as these core biomarkers have different surface charges in physiological conditions based on the isoelectric point (pI), we achieved a distinctive output signal for each biomarker. The gFET biosensor platform presented in this paper has great potential and can be used for early diagnosis of AD in clinical practice as well as accurate analysis based on the surface charge of the analytes.
科研通智能强力驱动
Strongly Powered by AbleSci AI